Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF)
Clinical trial NCT02139306 · COMPLETED
Trial details
- NCT number
- NCT02139306
- Sponsor
- PTC Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2016-11-01
- Enrollment
- 279
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.